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The enzyme ¢~ponsible for the synth~is of ¢ndoth¢lium-deriw.d relaxinll factor and/or nitric oxide in the endothelium has l:P~n de~:ril:~.d as  
particulate nzyme, wherea~ other isoforms of nitric oxide ~ynthase am soluble nzymes. Here we are reporting that endothelial cells m=tabolically 
incorporate myristate (C14). but not palmitate (C16). into nitric oxkh= syntha=. We are postulatinB that the ¢ndoth¢lial.dcrlved nitricoxide synthase 
is it particulate cnz~'mc becaur¢ el'the fatty acid acylation of the protein which "anchors' the enxTrne into the membrane ither dire=tly orvia another 
membrane-bound protein. 
Myristic acid; Palmiti¢ acid; EDRF; L.Arllinlnc; Bovine aortic endothelial c011 
I. INTRODUCTION 
Nitric oxide synthas¢ enzymatically converts L.Argin. 
in¢ and oxygen to i.-citrulline and nitric oxide (NO) 
[1--4], NO may bc involved in signal transduetion i  the 
bruin [$,6], is a cytostati¢ and tumori¢idal agent of cy- 
tokine or endotoxin-induced rnacrophages [7] (reviewed 
in [8])° is responsible for endotheliam-depcndeat v se. 
dilatation of vascular smooth muscle [9-11] and inhibi- 
tion ot" platelet agsregation [12]. Different ;.soforms of 
NO synthase have been puri~ed and characterized from 
the brain [13-16]. cytokinedendotoxin.induccd RAW 
maerophages [17.18], and endothelial c, lls [19] (re- 
viewed in [20]), Type I NO synthase isolated from rat, 
porcine, and human brain and Type III NO synthase 
isolated from bovine aortic endothelial cells are regu- 
lated by Ca:'/calmodulia [13-16,19,21]. The Type I NO 
synthas¢ is located in the soluble fraction of brain ho- 
mogcnatcs and the purified enzyme migrates at a molec. 
ular mass of 150-160 kDa under denaturing conditions 
[13-16], Type II NO synthase is a soluble, cytokine- 
inducible enzyme that do¢s not seem to be regulated by 
Ca"'Tcalmodulin, Its denatured molecular mass was de- 
termined to be about 130 kDa [1%18], In bovine aortic 
endothelial cells, Type I l l  NO synthase is located pre- 
dominantly (cultured cells [22] or ¢xclusiv¢ly (native 
cells [23]) in the particulate fraction with the purified 
enzyme from both sources migrating at a molecular 
mass of 135 kDa under denaturing conditions. [19] 
Therefore, we sousht to investigate the possible 
mechanisms involved in membrane association of the 
endothelial NO synthase. Some eukaryotic proteins are 
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co- or post-translationally modified by the addition of" 
a saturated fatty acid, such as myristat¢ (C14) or palmi- 
tare (C16), or a poly-isoprenc group, such a= farnesol 
(C15) or geranylseranol (C20), The= modifications can 
have profound effects on the sub~llular localization 
and function of the modified protein (r~iewed in [24]). 
Incubation of bovine aortic endothelial c~lls with 
[=Hlmyristate or [:~H]palmitate demonstrated th.-at only 
the myristat¢ was incorporated into Type III NO syn- 
these. 
2. MATERIALS AND METHODS 
Bovine aortic endothdial cells (BAE cells, pazsas¢ 9) [251 were 
Brown to approximately 80% confluence, in |?S cmz plates in Dul- 
b~_ceo's Modified E~sentiai Medium containing 10% fcml bovine 
farum (Oitmo). The medium was then rcmow.d and replac~ with l0 
ml alarum-free medium. Approsimately 350#uCi of[~H]myrlaie acid 
(NEN, 30.7 Ci/mmol) or [~H]palmitic acid (NEN. 30.7 Ci/mmol) was 
added per tissue culture plate. In some plat~, additional non.radiola- 
holed myristic acid or palmitic acid was added at a 100x molar atio. 
The cells were then incubated at 37"C for 4. 16, or 24 h. The cells did 
not reach conflucncy niter 24 h. [~H]Myflstic acid incorporation was 
found to b¢ siilnificantly less in confluent cells. 'rhc m¢dium was then 
removed and tile cells washed with phosphate.buffered salit)e (PnS) 
twice, Tile celLs were scraped from the plate,= in 5 ml of PBS and cech 
plate we=hod with 5 ml of PBS to insure complete =emoval of nit the 
cells. The cells were spun down at 4"C for 12 rnin at 2,200 rlPm, They 
were resusp,~nded in 1 ml of cold buffer 1 (50 mM Tris-HCI pH. 7,4. 
0,1 mM EDTA, 0.1 mM EGTA, and t n- mM 2.mera~ptoctlmnol) nnd 
homosenized in a 81asslteflon homoscnizer in the preserme of pretense 
inhabiters (I mM phcnylmethylsulfonyl fluoride, 1 pM l~pstatin A. 
.,3/JM leupeptin, and 1/JM aprotinin). The crude homo~=nmte,~ were 
centrifused at 100,000 x g for 60 rain. Th= ¢),tosolie fractions were 
removed and frozen at -70=C. The particulate tractions were resus. 
p=nded in 0.5 mlo1" buffer 2 (buffer 1 e.~ntainin$10% sly=roD, rcho- 
mogcnized in the pmlence of pretense inhabiters, olubiliz.cd with the 
c~aergem t 3-[(3-eda-ol~ _clap!' _¢spyl)dim-'thylammanio]- t .pmpane~ul. 
fonatc (CHAPS. SiBma; 20 raM) for 20 rain at 4"C with ~ntle rotation 
of the sample, and then rceantrlfu~ed at 100,000 x g for 30 man, The 
CHAPS extracts were removed and frozen at -70'C, The cytosolic 
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and CHAPS extract tractions from each variable condition were then 
loaded onto 200/zl columns of prcswollen 2',Y-ADP.Sepharor< (P'har- 
matin) and each fraction was r¢¢ireulated twice. Each column was 
washed with I ml of buffer 2 ¢ontainin$ 0.$ M NaCI and then with 
1 ml of buffer 2. The nitric oxide lyntha~ fraction was e..l ute.,d with 436 
/~1 of buffer 2 ~ntainlnli 10 mM NADPH (BochrinBer Mannh¢im) 
into microconcentrator units (10.00{2 mweo- Miilipore}, The buffers 
for the CHAPS axtract fractions all contain~ 10 n~M CHAI~. 
whereas the buffers for the soluble fractions contained no dctcrB~nt, 
The NADPH clmtt~ were th~n c~n=ntrat~d to approximately 36/zl 
volume=. Them ~mpl~ were run on ?.~denaturing SDS.PAGE [26] 
and stained with Coomar~ic bluc =to that the amount of nitric oxide 
lynthat¢ in each lane could ~ a,r~s_~jJ. No ditTeren== in protein 
content of each variable condition was ever noted (data not shown). 
TI~ i~1~ were then dcst~tin=d, exposed to the fluoro|raphic realist. 
EN~HANCE (DuPont-NEN), dr i l l ,  and cxpor, cd to Hyperfllm-MP 
(Amcrr~am) at -?O*C for 2 weeks. The films were prm__~__J with a 
Kodak.XO.mat pro~rdior. Dcnsitometry was performed with a l..¢ir~ 
Quantimet Q$?0 ironic analy'~r, Optical dcnslty readin~ were ~kcn 
acing th~ quantitative autoradiollraphi¢ tohwure of the image ana- 
ly'=r, 
3. RESULTS AND DISCUSSION 
The detergent (CHAPS) extract from BAE cells ho- 
mogenates purified on 2',5'-ADP.Sepharos~ produced 
approximately $ bands on a Coomassie blue.stained 
SDS-PAGE including the i 35 kDa band that represents 
Type Ill NO synthase [19]. This band was positively 
identified as endothelial NO synthase using a monoclo- 
hal antibody generated a~inst the purified particulate 
enzyme from BAE cells [27]. The corresponding autora- 
diography of a SDS-PAGE of 2",5'-ADP-Sepharos¢ pu- 
rified NO synthase prepared from BAE ¢.¢11s e.xposed to 
[~H]myristate alone during log growth demonstrated in-
corporation only in the 135 kDa band (Fig. I). In order 
to verify the specificity of this reaction, additional BAE 
cells were incubated in the presence of 100x molar ratio 
of unlabeled myristic acid. This markedly reduced the 
incorporation of [=H]myristate in the 135 kDa band 
(Fig. I). The ADP-purified soluble fraction from BAE 
~lls showed no measurable incorporation of radiola- 
belled mytistic acid, however the total amount of solu- 
bl= nitric oxide synthas¢ is very low [22] and none could 
bc detected by Coomassi¢ blue staining (data nnt 
shown). When the same experiments were repeated with 
[~H]palmitate, none of the particulate (Fig, I) or soluble 
(data not shown) proteins elated from 2',Y-ADP- 
Sepharose were labeled. 
Fatty acids may be oxidized and the resulting a=tyl- 
CoA fragments may be metabolically incorporated into 
amino acids for cellular protein synthesis, To ensure 
that the incorporation of radioactive myristic acid into 
NO synthase was specific, we incubated BAE cells with 
[=H]myristic acid for 4, 16 and 24 h. The same specific 
incorporation into Type III NO synthase was seen at 
each incubation time with an increase in intensity of the 
radioh~beled NO syntha~ with }ncre~_ 'mS incubation 
time (Table l). This suggests a speczfic modification of 
the endothelial NO synthase to be myristylated. Three 
known isoforms of NO synthase have now been cloned 
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Fill. I. Autoradio=raphic rmults of incorporation f[=H]myristic m:id 
and [=H'Jpalmitt¢ acid into endothelial NO w~thas¢. All  proteins 
~own w~m 2',Y-ADP.Sepharose purified from BAE cells and ran on 
a ?,S% denaturing SDS, PAGE as oullin~ in section 2. L~nm: ( i)  
Coomar~ic blue stained for total protein (arrow denote ,= the position 
of Type ill NO syntha==. 135 k Da): (2) incubation of BAE =lls with 
[~H]myriitate in the pre~nce of IO0 x unlabcle.d myristam for 16 h; 
(3} incubation of DAE ¢~lis with [~Hlmyristatc for 16 h; (4) incubation 
of BAE ¢~lls with [~l.I]palmitat¢ in the pr~rcn¢= of 100~ unlabeled 
plhnitate for 16 h: (:~} incubation of BAE nails with [~H]l'~lmitate for 
16 h, 
[28-32]. None of the enzymes appear to have a hydro- 
phobic signal sequence that would identify it as a mem- 
brnne-bound protein. However. the endothelial NO 
synthase [31.32] does poetess a consensus sea:tuence at 
the amino terminus for N-myristyl transferase [33]. 
Amino-terminal mydstylation involves an amide link- 
age to an amino-terminal slycyl residue catalyzed by the 
enzyme N-myristyl transferas¢ following the removal of 
the initiation methionine r~idue by the enzyme 
methioninc aminopcptidase. The amino-terminal Blycyl 
residue is critical to myristylation and at the fifth and 
eighth residues from the amino-terminal end ¢,¢rtain 
amino acids are also preferred. It has been shown that 
mTristylation is a very early co-translational event that 
occurs before the first 109 amino acids of a nascent 
polypeptide chain are polymerized [33-35]. Myristyla- 
lion of a protein may confer membrane association 
within a cell, although some proteins have been shown 
to be myristylated, but remain soluble proteins [24], We 
postulate for Type III NO synthase that myristylation 
determines its predominant localization in the particu- 
late fraction of BAE cells. The second form of fatty acid 
Toble l 
Absolute optical denshy or autoradiosraphs from SDS-PAGE of the 
Type lil NO syntha~ protein hand 
Time Optical dcnshy Optical density 
[~H]myristate only [~H]myristate 
plus lO0 x unla~lcd 
myristate 
4 h 6.0035 0.0002 
16 h 6,0183 0,0015 
24 h 6.0171 6.00(]3 
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acylation known involves the ~terification of palmitate 
with sefine or threonine, or with cysteine to form the 
corr~pondin~ thioester. Palmitation appears to be ex- 
clusively a post.translational event and no consensus 
sequence has been elucidated yet [24.33-35], We found 
no evidence for pMmitation of'endothelial NO synth~¢ 
(Fig. I), Also, no consensus sequence for prenylation at 
the carboxy-terminus of the enzyme was found in the 
predicted amino acid sequence of Type [II NO synthase 
[31,32]. which is consistent with our findinB of no 
change in the sub~llular localization of endothelial NO 
synthase activity after inhibition of HMO-CoA- reduc-  
tas¢ with lovastatin (unpublLshed results), 
Th¢ Type I NO synthase from rat brain and Type [l 
isoform from induced macrophages are both soluble 
proteins [13-18] and the cloned amino acid sequences 
do not contain an N-myristyl transferase consensus se- 
quen~ [21~-30]. In addition to the mainly soluble activ- 
ity. smaller quantities of particulate NO synthase activ- 
ity has been found in cytokine-indu~d macrophages 
[35--38] and a recent report susl~ests the presence of a 
150 kDa insoluble NO symhase in the rat c~rebellum 
[39]. The nature of these particulate NO syntha~es i  
unclear at this time, 
In conclusion, we postulate that endothelial Type II1 
NO synthas¢ incorporates a saturated fatty acid, m)'ris. 
tale, but not palmitat¢, which determines its membrane 
a~sociation. In vitro muta~¢n~is studies that substitute 
the N-terminal Blycin¢ of endothelial NO synthase will 
have to be performed to corroborate this finding,, 
Myristylation may facilitate Type III NO synthase 
binding to a cellular membrane directly or via a myristyl 
protein receptor similar to the myristylated pp60""" 
protein [40]. 
Acknowledgements: The author,~ would like to Iiratefully acknowledge 
Dr. Ma~mk[ Nakan¢ and Dr, Harald Schmidt for their helpful di~us. 
Lions throuilhout the course of these experiments and we would like 
to acknowledlle Dr. Mahlon Miller and Gerald Gallne for their help 
in th~ imai~e analyes "F the autoradiosraphs and the excellent teehni- 
~i a~istanee oiZ¢i-Jin8 Huanll. This work was supported in part by 
iltant$ from the National Institutes of Health (HL 2~4?4 and DK 
30781), 
REFERENCES 
[I) Palmer. R,M,I,o Athton, D.S. and Moncnda, S, (19B8} Nature 
333, 646-666, 
[2l Schmidt, H.H.H,W,, Nan, H., Wittfoht. W.. Gerlaeh, J,. Prea- 
cher, ~,E., Klein, M.M,, Niroomand, F. and Bt~hmc, E.(1988) 
Ear, J. Pharma¢,ol. 15d, 213-216, 
[31 Knowl~, R,G,, Palacios, M., Palmer, R.M,J. and Moncada, S. 
(1989) Prec. Null, Aesd, Sci, USA 86. 5159-S162. 
[4] Tayeh, M,A. and Marietta, M.A, (19S9) J. i]iol. Chem, 264, 
196~4.-19658. 
[5] Gatthwaite, J., Charles. S,L. and Chess-Williams. R, (198B) Na- 
ture 336, 385-31~8. 
[6] Br¢.dt, D,S. and Snyder, S,H, (1989) Prec, Null, Acad. 5¢i. USA 
86, 9030-9033, 
[7] Hibbs Jr,, J.B,, Taintor, R,R, and Vavrin, Z, (.1987) Science 235. 
M3..~76, 
(Ill Nathan, C.F, and Hibbs Jr., J.B, fig91) Cuff. Opin. [mmunol, 
3, 6:5-70. 
(9l FurchBott, R.F. and Zatwadzki. J V. (191~0) Nature 2tRl, 3?3-3?6, 
[10] Rapoport. R.M, and Murud, F, (1983) Circ. Rcs, S2, 352-3S?. 
[I I) Murad, F. (19~6) J. Ciin. lmmst. "/8, I-S. 
[12l All'~id, U.. Fr~lich. J,C, and F~rstcrmann, U. (1911"/) Thromb, 
Rcs. 4?, 561-5"/I, 
[13| Brat, D. and Snyder, S, (1090) Prec. Natl. Aead. Set, USA 87. 
682-~S. 
[14] ~hmidt. H,H,H,W., Pollock, J,$., Nakan¢, M,, Gonky, L,D,. 
FM~tcrrnann. U. and blurad, F. (1991) Prec. Natl. Ae.ad, Sci. 
USA 88, 365-369. 
[151 Mawr, B.. John, M, and I]~hme, E. (1990) FEDS Left, 297, 
215-219, 
[16] Schmidt. H,H.H.W, and Muntd, F. (1991) Biechem. Bioph~. 
Res, Comm. 1111. 13?2-13TL 
[17] Stuehr, D.,I,. Cho. HJ .  Kwon, N,S. and Nathan, C,F. 0991) 
Pro¢. Null, Acid. Sci. USA g11, 7?"/3-97??, 
(L8] He~l, .I., White, K.A. and Marietta, M.A. (1991).I, Biol Chem, 
266, 22?119.-2279 i, 
(19] Pollock. J,S.. F~rstermann, U., Mitchell. LA.. Warner, T,D,. 
Schmidt. H,H,H,W,. Nakane. M, and Murad. F. (1991) Prec, 
Natl. Acad, flci. USA till, 10480.-104~, 
[203 F6rstemmnn. U. 5¢hmldt, H.H.H.W., Pollock, LS.. Shenil, H,, 
Mitchell, J.A.. Warner. T,D., Nakane. M, and Murad, F. (1991) 
l]iochcm. Pharm. 42, IINg-IB$?. 
(21] MtH~h. A, m~d Buue, R, (1990) FEBS Left, 26S, 133-136. 
[22] FMstem~ann, U,. Pollock, J,S,, Schmidi, H.H.H,W., Hailer, M. 
and Murad, F, (1991} Proc, Natl. Acad, Sci, USA 81~, 171111-1?92, 
[23l Mitchell, J,A., FOrsiermann, U., Warner, T,D,. Pollock, J.S,, 
Schmidt, H,H,H.W.. Hdler, M. and Murad, F. O991) Biochem, 
Biophys. Res, Commun, 176, 1417-1423, 
(24] De.schen~, R.,I,, Rash. M,D, and Bro.'teh. J,R, (1990) Curt, Opin, 
Cell. Biol. 2. 1108-1113, 
[2S) L~itman. D.. Watclman, S.A,. Rapoport. R,M. and Murad, F. 
(191iS) Trans Au, ec, Am, Ph~irdans 915. 243-252, 
[26] Lmcmmli. U.K. (1970) Nature 227. 680-685, 
[27] Pollock..I,S. Nakane. M,. Sprinpli. D.R,, Htmns, Z..&., Mit. 
chell, .I,A., Warner. T.D,. Polak. J.M., F~r-dermann, U, and 
Murad. F. 0992) J. Var¢, Res, 29. 1~4. 
[28] Brcdt, D,S.. Hwan11, P,M.. Glatt, C,E., Lowenstein, C.. Reed, 
R.R. and ~nyder. S,H. (1991) Nature 33I, -/14.-718, 
[29] Lyons, C,R.. OrlolT0 G,J, and Cunningham, J.M, (1992) J, Biol, 
Chem, 267, 6370-6374. 
[30] Xie. Q.-W,. Cho. H.L. Calaycay. J.. Mumford, R.A,, Swiderck, 
K.M,, Lo:, T.D,, Dins, A., Troso, T. and Nathan, C, 0992) 
Selcnc¢ 2S6, 225-228. 
[31] Lamal. S,, Li, G.K,. Mat~den, P., Tempst, P. and Michel, "1. 
0992) J. Vase. R~. 29, 133, 
[32] Sctr, a, W.C., Harrison, J.K., 13arbara, C.M., Zcnll, D., Durieux, 
M.E,, D'An~lo, D,D., Lynch, K,R. and Peach, M.J. 0992) J, 
Biol. Chem. 267, in press, 
[33) Kaplan, .I,M., Mardon, G,, Bishop, J,M. and Varmus, H.E. 
(1981]) Mol. Cell. Biol. 8, 243S-2441. 
[34| MaB=, A,I. and Courtneld~, B.A. (1985) EMBO I. 4, 1131- 
i144, 
[3S] Mellhimmey, R.A,J., Pdly, S,.I,. Chadwick. J,K, and Cowley. 
G.P. (1985) EMBC) J. 4, 1145-1152. 
(35] Hiki, K., Yui, Y,, Hattori, R., Eizawa, H,, Ko,KuSa, K. and 
Kawai, C, (1991) Jn. J. Pharm, 56, :217-220, 
[37] F~rstermann, U., Sehmidt, H,H.H,W.. Kohlhaas, K.L. and 
Murad, F, (1992) Ear, ,I, Pharmacol, Mol, Pharmucol, 225, 161- 
165, 
[319 ~hmidt. H.H.H.W,. Warner, T.D,, Nakane. M,, F0rstermann, 
U, and Murad, F. 0992) Mol, Pharm. 41,615-624, 
[39] Hiki, K,, Hattori, R., Kawai, C, and Yui, ¥, (1992) .i. Bioehem. 
111,556-558, 
[40] Rash, M.D, and LinB, H.P, (1990) Natu~ 346, 84.-B6. 
404 
